Skip to main content
. 2022 Mar 29;2(2):139–153. doi: 10.1016/j.jacasi.2022.02.004

Figure 2.

Figure 2

Effect of Dapagliflozin on Cardiovascular Outcomes According to Geographic Region

The primary outcome was a composite of death from cardiovascular causes, hospitalization for heart failure, or an urgent visit resulting in intravenous therapy for heart failure. The cumulative incidences of (A) the primary outcome, (B) hospitalization for heart failure, (C) death from cardiovascular causes, and (D) death from any cause were estimated with the use of the Kaplan-Meier method.